D
Donald G. Klepser
Researcher at University of Nebraska Medical Center
Publications - 71
Citations - 1349
Donald G. Klepser is an academic researcher from University of Nebraska Medical Center. The author has contributed to research in topics: Pharmacy & Pharmacist. The author has an hindex of 17, co-authored 64 publications receiving 1121 citations.
Papers
More filters
Journal ArticleDOI
Comprehensive Medication Therapy Management: Identifying and Resolving Drug-Related Issues in a Community Pharmacy
TL;DR: The MTM program showed that drug therapy for ambulatory patients taking multiple medications to treat chronic conditions can be improved through collaboration between physicians and community pharmacists.
Journal ArticleDOI
Proton pump inhibitors and acute kidney injury: a nested case–control study
TL;DR: Renal disease was positively associated with PPI use and patients with a renal disease diagnosis were twice as likely to have used a previous prescription for a PPI, even after controlling for potential confounding conditions.
Journal ArticleDOI
Reduction in mortality associated with statin therapy in patients with severe sepsis.
TL;DR: Evaluating the effect of 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitors (statins) on mortality in patients with severe sepsis found them to be safe and effective.
Journal Article
Adherence and dosing frequency of common medications for cardiovascular patients
Jay P. Bae,Paul P. Dobesh,Donald G. Klepser,Johnna Anderson,Anthony Zagar,Patrick L. McCollam,Molly Tomlin +6 more
TL;DR: In this large analysis, the QD dosing regimen was related to greater adherence versus a BID regimen, and the adjusted mean MPR value was similar between QD and BID agents.
Journal ArticleDOI
Effectiveness of a pharmacist-physician collaborative program to manage influenza-like illness
Michael E. Klepser,Donald G. Klepser,Allison M. Dering-Anderson,Jacqueline A. Morse,Jaclyn K. Smith,Stephanie A. Klepser +5 more
TL;DR: Using an evidence-based CPA, pharmacists were able to provide timely treatment to patients with and without influenza and this study describes a physician-pharmacist collaborative model for treating ILI.